$Zymeworks(ZYME)$ 今天波动怎么这么大，最新的消息是跟辉瑞palbociclib联用啊，ZW49的消息也是正面的。

An interim update from the ongoing ZW49 Phase 1 dose-escalation study highlighted that there have been no dose-limiting toxicities observed and the maximum tolerated dose has not been reached. With over ten patients treated, the majority of treatment-related adverse events have been grade 1 or 2, and were reversible and manageable on an outpatient basis. Importantly, preliminary results from these initial dose cohorts include anti-tumor activity.